Biogen to Pay Genentech in Cancer-Drug Collaboration
Bloomberg
Fri, 10/31/08 - 08:57 am
ImClone's Erbitux to Get Quicker Review by U.S. FDA
Bloomberg
Fri, 10/31/08 - 08:48 am
AstraZeneca Chooses Acquisitions Over Buybacks, Joining Glaxo
Bloomberg
Thu, 10/30/08 - 12:08 pm
Mylan Profit Jumps 15% on Sale of Blood-Pressure Drug
Bloomberg
Thu, 10/30/08 - 12:06 pm
Novo May Spend as Much as $2 Billion on Takeovers
Bloomberg
Thu, 10/30/08 - 12:06 pm
Drug stocks rally in wake of Fed rate cut
Marketwatch
Thu, 10/30/08 - 12:05 pm
A Strong Season for AstraZeneca’s Cholesterol Drug Crestor
WSJ Online
Thu, 10/30/08 - 12:03 pm
Do Newly-Released FDA Memos Hurt Wyeth’s Preemption Argument?
WSJ Online
Thu, 10/30/08 - 11:27 am
Glaxo's Avandia Should Be Banned, Public Citizen Says
Bloomberg
Thu, 10/30/08 - 11:14 am
Elan, Biogen Plunge After Brain Illness Strikes Tysabri Patient
Bloomberg
Thu, 10/30/08 - 11:10 am
Johnson & Johnson: Still Adding to My Position
Seeking Alpha
Thu, 10/30/08 - 11:09 am
AstraZeneca Beats Forecasts, Raises Year Guidance
CNBC
Thu, 10/30/08 - 11:08 am
More R&D: Not Boosting Big Pharma
Businessweek
Thu, 10/30/08 - 11:08 am
How Many People Take Cholesterol Drugs?
Forbes
Thu, 10/30/08 - 11:06 am
Wyeth Cuts Back Too: Are New Opportunities Being Created?
Seeking Alpha
Thu, 10/30/08 - 11:05 am
GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
Yahoo/AP
Thu, 10/30/08 - 11:04 am
FDA Official: Preemption Argument ‘Based On a False Assumption’
WSJ Online
Thu, 10/30/08 - 10:49 am
Wyeth narrowing focus of research to 6 areas, shifting women's health research to new diseases
Yahoo/AP
Thu, 10/30/08 - 10:49 am
Biotech funding crisis poses risks to innovation
Guardian, UK
Wed, 10/29/08 - 05:24 pm
Biogen Says Brain Illness Found in Tysabri Patient
Bloomberg
Wed, 10/29/08 - 05:22 pm

Pages